Stay updated on Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added related topics Melanoma and MedlinePlus Genetics. Updated site revision from v3.4.2 to v3.4.3.
    Difference
    0.2%
    Check dated 2026-03-06T18:15:43.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Removed the Melanoma label and the related topics: MedlinePlus Genetics from the page.
    Difference
    0.2%
    Check dated 2026-02-27T18:59:02.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Minor metadata updates: the page now shows a new revision label (v3.4.2) and adds the Melanoma keyword along with related topics such as MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-13T12:36:25.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated to v3.4.1. Melanoma and related topics (MedlinePlus Genetics) were removed, and the reference to Revision: v3.4.0 was deleted.
    Difference
    0.2%
    Check dated 2026-02-05T13:43:39.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now lists Melanoma as a topic and adds a related topics link to MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-22T06:24:36.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now includes a new revision note (Revision: v3.3.4) and removes certain topics (Melanoma and MedlinePlus Genetics) as well as the prior revision tag (Revision: v3.3.3). These updates are metadata/navigation changes and do not affect the trial's core details, eligibility criteria, or results.
    Difference
    0.2%
    Check dated 2026-01-15T03:04:47.000Z thumbnail image

Stay in the know with updates to Nivolumab + HF10 for Resectable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + HF10 for Resectable Melanoma Clinical Trial page.